These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 16741025)
1. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats. Jesmin S; Zaedi S; Maeda S; Yamaguchi I; Goto K; Miyauchi T Exp Biol Med (Maywood); 2006 Jun; 231(6):925-31. PubMed ID: 16741025 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart. Jesmin S; Zaedi S; Yamaguchi N; Maeda S; Shimojo N; Masuzawa K; Yamaguchi I; Goto K; Miyauchi T Exp Biol Med (Maywood); 2006 Jun; 231(6):902-6. PubMed ID: 16741021 [TBL] [Abstract][Full Text] [Related]
3. Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats. Jesmin S; Zaedi S; Yamaguchi N; Maeda S; Yamaguchi I; Goto K; Miyauchi T Exp Biol Med (Maywood); 2006 Jun; 231(6):1034-9. PubMed ID: 16741044 [TBL] [Abstract][Full Text] [Related]
4. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055 [TBL] [Abstract][Full Text] [Related]
5. Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats. Miyauchi Y; Jesmin S; Sakai S; Kamiyama J; Shimojo N; Rahman A; Islam M; Zaedi S; Maeda S; Maruyama H; Mizutani T; Homma S; Aonuma K; Miyauchi T Life Sci; 2014 Aug; 111(1-2):6-11. PubMed ID: 24953608 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor in diabetes induced early retinal abnormalities. Cukiernik M; Hileeto D; Evans T; Mukherjee S; Downey D; Chakrabarti S Diabetes Res Clin Pract; 2004 Sep; 65(3):197-208. PubMed ID: 15331199 [TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise. Maeda S; Miyauchi T; Iemitsu M; Tanabe T; Goto K; Yamaguchi I; Matsuda M Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E609-14. PubMed ID: 14665447 [TBL] [Abstract][Full Text] [Related]
8. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina. Cukiernik M; Hileeto D; Downey D; Evans T; Khan ZA; Karmazyn M; Chakrabarti S Diabetes Metab Res Rev; 2004; 20(1):61-71. PubMed ID: 14737747 [TBL] [Abstract][Full Text] [Related]
9. Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia. Gupta A; Sharma AC Shock; 2003 Oct; 20(4):375-81. PubMed ID: 14501953 [TBL] [Abstract][Full Text] [Related]
11. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts. Jesmin S; Zaedi S; Shimojo N; Iemitsu M; Masuzawa K; Yamaguchi N; Mowa CN; Maeda S; Hattori Y; Miyauchi T Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1030-40. PubMed ID: 17148754 [TBL] [Abstract][Full Text] [Related]
12. Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats. Luo L; Dai DZ; Cheng YS; Zhang Q; Yuan WJ; Dai Y J Pharm Pharmacol; 2011 Jul; 63(7):943-51. PubMed ID: 21635260 [TBL] [Abstract][Full Text] [Related]
13. The effects of alpha-lipoic acid on nitric oxide synthetase dispersion in penile function in streptozotocin-induced diabetic rats. Hurdag C; Ozkara H; Citci S; Uyaner I; Demirci C Int J Tissue React; 2005; 27(3):145-50. PubMed ID: 16372481 [TBL] [Abstract][Full Text] [Related]
14. Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Yamaguchi N; Jesmin S; Zaedi S; Shimojo N; Maeda S; Gando S; Koyama A; Miyauchi T Peptides; 2006 Sep; 27(9):2258-70. PubMed ID: 16725227 [TBL] [Abstract][Full Text] [Related]
15. Endothelial nitric oxide synthase expression in systemic and pulmonary circulation of streptozotocin induced diabetic rats: comparison using image analysis. Sridulyakul P; Chakraphan D; Bhattarakosol P; Patumraj S Clin Hemorheol Microcirc; 2003; 29(3-4):423-8. PubMed ID: 14724370 [TBL] [Abstract][Full Text] [Related]
16. EPA effect on NOS gene expression and on NO level in endothelin-1-induced hypertrophied cardiomyocytes. Shimojo N; Jesmin S; Zaedi S; Soma M; Kobayashi T; Maeda S; Yamaguchi I; Goto K; Miyauchi T Exp Biol Med (Maywood); 2006 Jun; 231(6):913-8. PubMed ID: 16741023 [TBL] [Abstract][Full Text] [Related]
17. Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats. Lu YL; Hu SJ; Shen ZJ; Shao YC Chin Med J (Engl); 2004 Aug; 117(8):1165-9. PubMed ID: 15361289 [TBL] [Abstract][Full Text] [Related]
18. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022 [TBL] [Abstract][Full Text] [Related]
19. Alterations in gene expressions encoding preproET-1 and NOS in pulmonary tissue in endotoxemic rats. Zaedi S; Jesmin S; Maeda S; Shimojo N; Yamaguchi I; Goto K; Miyauchi T Exp Biol Med (Maywood); 2006 Jun; 231(6):992-6. PubMed ID: 16741036 [TBL] [Abstract][Full Text] [Related]